Fulcrum Therapeutics FULC
NASDAQ FULC
$3.68 -0.02 (-0.54%)
At close: Oct 22, 2026 · 4:00 PM EDT

Fulcrum Therapeutics (FULC) Preferred Stock Liabilities (2018 - 2019)

Updated

Fulcrum Therapeutics (FULC) reported Preferred Stock Liabilities of $165.14 million for Q2 2019, up 175.6% from $59.91 million a year earlier and unchanged from the prior quarter.

Analysis

Fulcrum Therapeutics (FULC) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends

At the end of FY2018, Fulcrum Therapeutics posted Preferred Stock Liabilities of $139.67 million.

  • Per Business Quant data, the three quarters before Q2 2019 came in at $165.14 million (Q1 2019), $139.67 million (Q4 2018) and $139.67 million (Q3 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Fulcrum Therapeutics 278.74 Mn -64.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 165.14 Mn
Mar 31, 2019 165.14 Mn
Dec 31, 2018 139.67 Mn
Sep 30, 2018 139.67 Mn
Jun 30, 2018 59.91 Mn
API Access

Fulcrum Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=FULC&period=max&api_key=YOUR_API_KEY